Incision Management: The Final Step for Complex Surgical Procedures

On-Demand Webcast

Allen Gabriel, MD, FACS
Associate Professor of Surgery
Loma Linda University Medical Center
Loma Linda, California
Peacehealth Southwest Medical Center
Vancouver, Washington

Devinder Singh, MD
Associate Professor of Surgery
University of Maryland School of Medicine
Section Chief of Plastic Surgery
VA Hospital – Baltimore
Baltimore, Maryland

Intended Learners

This activity is designed for physicians,pharmacists, podiatrists, physical therapists, and nurses.

Learning Objectives

After completion of this activity, participants should be able to:

  • Recognize the impact of surgical care complications as it relates to postoperative infections and identify patient populations at risk for surgical site compromise
  • Review considerations for steps to take when surgical site disruption occurs with the goal of achieving wound closure
  • Explore the role of incision management to reduce the risk of wound infection and dehiscence
  • Employ best practice protocols in preventing surgical site infections 
Activity Overview

This on-demand webcast is available with synchronized slides and audio.

To be eligible for documentation of credit, participants must complete the educational activity, read the article, complete the 10 question post-test with a score of 70% or better, and complete the evaluation form.

ACPE Credit Policy

Your official record of ACPE credit will be generated through the CPE Monitor System. The certificate printed from this website after completing the evaluation for this activity is for personal tracking purposes only.

Eligibility for pharmacy credit is contingent upon the successful completion of a post-test and/or evaluation for each activity or session attended. Please note that you must complete the activity evaluation within 60 days of a live activity or within 60 days of beginning the evaluation for an enduring activity. Under ACPE Policy, NACCME will not be able to report your activity completion to CPE Monitor after this 60-day period.

After successful completion of the post-test and evaluation form online at, participants may immediately print their documentation of credit.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

Date of last review: November 21, 2017
Release date: May 18, 2015
Expiration date: November 30, 2019
Estimated time to complete: 45 minutes

There is no fee associated with this activity.

For questions regarding this educational activity, please call 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested for video programs. A PDF reader is required for print publications. Please direct technical questions to


  In support of improving patient care, North American Center for Continuing Medical Education (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


NACCME designates this enduring material for a maximum of .75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.


This continuing nursing education activity awards .75 contact hours.



This educational activity is approved for 0.75 contact hour (0.075 CEU) of continuing pharmacy education  (UAN JA0006201-0000-19-040-H01-P)

This Educational Activity is a Knowledge-Based Activity.

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact the Senior Manager, Accreditation & Compliance, NACCME, in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. The Senior Manager, Accreditation & Compliance will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Senior Director, Accreditation and Compliance, NACCME, may be made for a second level of review.

Continuing Podiatric Education

North American Center for Continuing Medical Education, LLC (NACCME) is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. NACCME has approved this activity for a maximum of .75 continuing education contact hours.

Independent Clinical Reviewer: Alan Dardik, MD, PhD, Associate Professor of Surgery, Yale University School of Medicine, Chief, Peripheral Vascular Surgery, VA Connecticut Healthcare Systems, Bethany, Connecticut.

Nurse Planner: Susie Seaman, NP, Sharp Rees-Stealy Wound Clinic, San Diego, California.

Planning Committee

The planning committee comprises Alan Dardik, MD, PhD, FACS, FAHA, Allen Gabriel, MD, Susie Seaman, NP, Devinder Singh, MD; Kristin Ciszeski, Carolyn Drake, Tiffney Oliver, Randy Robbin, Lynn Rubin, and Sydney Turner, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty have reported the following:

Dr. Gabriel: Consultant—Acelity, Allergan
Dr. Singh: Consultant—Acelity, Novadaq
Ms. Seaman: Scientific advisor – Smith & Nephew, Inc.; Mölnlycke Health Care; Promotional Speakers’ Bureau – Smith & Nephew, Inc.

Dr. Dardik has disclosed no relevant financial relationships with any commercial interest.

Ms. Ciszeski, Ms. Drake, Ms. Oliver, Mr. Robbin, Ms. Rubin, and Ms. Turner have disclosed no relevant financial relationships
with any commercial interest.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed
in their presentations.

The faculty have disclosed that no off-label/unapproved drugs and/or devices will be discussed.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2017 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Grant Support

Supported by an educational grant from Acelity

Access Webcast
0.75 CME
0.75 CNE
0.75 CPE
0.75 CPME